Topic:

Financials

Latest Headlines

Latest Headlines

Clinverse reels in a $9.1M funding round to expand its trial tech

Durham, NC's Clinverse has put together a $9.1 million C round, raising cash to support its technology for managing costs in clinical trials.

Medtronic stumbles in India, China but holds up in U.S.

Medtronic has tied its long-term growth to three pillars: strong U.S. sales, double-digit growth in emerging markets and Covidien. But last quarter, the medical device giant didn't deliver on emerging market revenue growth as it encountered difficulties with distributors in India and China. It expects to return to double-digit gains in both countries this fiscal year.

VC Rock Health partners with Abbott, expands digital health portfolio

Venture Capital firm Rock Health announced today that it is adding 8 digital health companies to its portfolio and partnering with three industry bigwigs, including Abbott.

Big Pharma doesn't win the margin stakes. That's Jazz, Celgene, Regeneron and Alexion

Margins, margins, margins. That's an inevitable mantra among top investors and analysts. Just ask Novartis CEO Joe Jimenez, who's pledged big improvements in the Swiss drugmaker's spread. Or Eli Lilly CFO Derica Rice, who's had to explain why his company can promise to maintain margins as its sales spiral downward.

AMRI swings to revenue growth amid a transitional year

Contract drug developer AMRI posted a 15% boost in its quarterly revenue, using M&A and manufacturing demand to help wean it off royalty cash.

Evotec rides its risk-sharing model to revenue growth

German contract researcher Evotec posted 9% growth in the first half of 2014, executing on its plan to serve as both CRO and proprietary developer in a hybrid approach to R&D.

Sales of pet products take a dive at Central Garden & Pet

Central Garden & Pet, which is being stalked by the Harbinger Group hedge fund, saw its third-quarter sales ending June 28 decrease by 11% to $438 million. The marketer and producer of branded products for the lawn and garden and pet supplies markets saw revenues decline in both segments.

Kindred Biosciences' loss grows in the face of development costs

San Francisco-based Kindred Biosciences saw its loss swell for the second quarter as it continued development of new drugs including CereKin, a drug for canine osteoarthritis, based off studies for Amgen and Pfizer's Enbrel.

WuXi's manufacturing boom spells a big quarter

WuXi PharmaTech, China's largest CRO, boosted its revenue by 14.8% in the second quarter, as banner growth in its contract manufacturing business helped the company expand its global reach.

Wearable and 3D printing companies raise more than $63M on Kickstarter, Indiegogo

Wearable device companies have raised at least $38.5 million on crowdfunding sites Kickstarter and Indiegogo, and 3D printing companies at least $25.6 million, according to calculations by Matt Witheiler, general partner at Flybridge Capital Partners. The statistic includes more than 80 companies that have raised more than $100,000.